Oct 3 (Reuters) – Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and WeightWatchers once it gets U.S. approval, Bloomberg News reported on Friday. (Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Steve Gorman Feb 6 (Reuters) - Actor Timothy Busfield, known for his U.S. prime-time…
VEGA BAJA, Puerto Rico, Feb 6 (Reuters) - In the small coastal Puerto Rican town…
VEGA BAJA, Puerto Rico, Feb 6 (Reuters) - In the small coastal Puerto Rican town…
By Danielle Broadway LOS ANGELES, Feb 6 (Reuters) - American rapper Lil Jon said on…
By Keith Weir, Elvira Pollina and Julien Pretot MILAN/CORTINA D'AMPEZZO, Italy, Feb 6 (Reuters) -…
By Keith Weir, Elvira Pollina and Julien Pretot MILAN/CORTINA D'AMPEZZO, Italy, Feb 6 (Reuters) -…